Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, risk management, and public policy. Peter began covering markets at Multex (Reuters) ...
Cyclacel Pharmaceuticals, Inc. announced a 1-for-15 reverse stock split of its common stock, effective July 7, 2025, with trading commencing on a split-adjusted basis that day under the ticker symbol ...
NEW YORK, Aug. 4, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback